Working… Menu

Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02772094
Recruitment Status : Unknown
Verified May 2016 by Wen-Kuang Yang, MD PhD, China Medical University Hospital.
Recruitment status was:  Active, not recruiting
First Posted : May 13, 2016
Last Update Posted : May 13, 2016
Den-Mei Brain Tumor Education Foundation, Taichung, Taiwan
Ministry of Health and Welfare, Taiwan
Information provided by (Responsible Party):
Wen-Kuang Yang, MD PhD, China Medical University Hospital